The present disclosure provides agents cap able of promoting endogenous steroid production (such as endogenous testosterone production) without altering the en dogenous luteinizing hormone. The present disclosure also provides associated therapeutic methods as well as screening assays for identifying further therapeutic agents for the pre vention, treatment and/or alleviations of symptoms associ ated with hypogonadism.